Research Directory

EU guides on the use of AI in medicines regulation

Read more

The weight loss sector continues to evolve

Read more

GLP-1 agonist shortages set to continue

Read more

More advanced planning needed for antimicrobials

Read more

New antibiotics pass regulatory hurdles

Read more

GLP-1 agonists shake up the sector

Read more

FDA guidance on drugs for early Alzheimer's disease

Read more

EMA reflects on 2023

Read more

EMA adopts AI workplan

Read more

EMA launches consultation on AI

Read more